NCT05141760View on ClinicalTrials.gov

18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI)

Additional staging PET and MRI scan prior to prostatectomy and lymph node dissection

Trial Locations (1)

T6G 2B7

University of Alberta, Edmonton

All Listed Sponsors
collaborator

Canadian Urological Association Scholarship Foundation

UNKNOWN

lead

University of Alberta

OTHER